Menu

Experience

Phillip McGill

    • Castle Biosciences $74 Million IPO 


    • Atlassian - $531 Million IPO 


    • Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb 


    • Cidara Completes Initial Public Offering  


    • Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering 


    • Bellicum Pharmaceuticals $160 million IPO 


    • Ionis Pharmaceuticals Completes Rule 144A Offering of $500 Million of Convertible Senior Notes 


    • Ionis Pharmaceuticals Completes Rule 144A Offering $500 Million of Convertible Senior Notes 


Contact us

Back to top

© 2019 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.